1. Home
  2. PGC vs ERAS Comparison

PGC vs ERAS Comparison

Compare PGC & ERAS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PGC
  • ERAS
  • Stock Information
  • Founded
  • PGC 1921
  • ERAS 2018
  • Country
  • PGC United States
  • ERAS United States
  • Employees
  • PGC N/A
  • ERAS N/A
  • Industry
  • PGC Commercial Banks
  • ERAS Biotechnology: Pharmaceutical Preparations
  • Sector
  • PGC Finance
  • ERAS Health Care
  • Exchange
  • PGC Nasdaq
  • ERAS Nasdaq
  • Market Cap
  • PGC 536.5M
  • ERAS 439.7M
  • IPO Year
  • PGC N/A
  • ERAS 2021
  • Fundamental
  • Price
  • PGC $28.00
  • ERAS $2.59
  • Analyst Decision
  • PGC Strong Buy
  • ERAS Buy
  • Analyst Count
  • PGC 2
  • ERAS 6
  • Target Price
  • PGC $37.00
  • ERAS $3.83
  • AVG Volume (30 Days)
  • PGC 94.3K
  • ERAS 2.1M
  • Earning Date
  • PGC 10-22-2025
  • ERAS 11-11-2025
  • Dividend Yield
  • PGC 0.72%
  • ERAS N/A
  • EPS Growth
  • PGC N/A
  • ERAS N/A
  • EPS
  • PGC 1.81
  • ERAS N/A
  • Revenue
  • PGC $238,300,000.00
  • ERAS N/A
  • Revenue This Year
  • PGC $29.31
  • ERAS N/A
  • Revenue Next Year
  • PGC $18.30
  • ERAS N/A
  • P/E Ratio
  • PGC $15.39
  • ERAS N/A
  • Revenue Growth
  • PGC 16.62
  • ERAS N/A
  • 52 Week Low
  • PGC $23.96
  • ERAS $1.01
  • 52 Week High
  • PGC $37.88
  • ERAS $3.31
  • Technical
  • Relative Strength Index (RSI)
  • PGC 47.26
  • ERAS 73.25
  • Support Level
  • PGC $26.79
  • ERAS $2.21
  • Resistance Level
  • PGC $28.74
  • ERAS $2.65
  • Average True Range (ATR)
  • PGC 0.65
  • ERAS 0.21
  • MACD
  • PGC -0.13
  • ERAS 0.06
  • Stochastic Oscillator
  • PGC 35.75
  • ERAS 89.39

About PGC Peapack-Gladstone Financial Corporation

Peapack Gladstone Financial Corp provides banking services. It operates through two segments namely Banking, which involves the delivery of loans and deposits, and Wealth Management Division which includes asset management services. The banking segment includes commercial real estate, multifamily, residential and consumer lending, deposit generation, and Internet banking services. Wealth Management includes investment management services for individuals and institutions; personal trust services, administrator, custodian and guardians, and other financial planning and advisory services. The services provided by the company include checking and savings accounts, money market and interest-bearing checking accounts, certificates of deposit, individual retirement accounts, and other services.

About ERAS Erasca Inc.

Erasca Inc is a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company's product pipeline includes; Naporafenib, a pan-RAF inhibitor with first-in-class potential in NRASm melanoma, RAS Q61X tissue agnostic solid tumors, and other RAS/MAPK pathway-driven tumors, and ERAS-007 (oral ERK1/2 inhibitor) and ERAS-601 (oral SHP2 inhibitor), which target downstream and upstream nodes, respectively, of the RAS/MAPK pathway.

Share on Social Networks: